Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Clinical Trial to Slow the Progression of ADPKD

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified November 2005 by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
Recruitment status was:  Not yet recruiting
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00067977
First received: September 3, 2003
Last updated: November 2, 2005
Last verified: November 2005
  Purpose
This study will determine whether certain blood pressure medications will slow cyst growth or keep kidneys functioning longer in patients with autosomal dominant polycystic kidney disease (ADPKD). The study will take place at several sites in the United States. The start date of the study has not yet been determined.

Condition Intervention
Kidney, Polycystic
Kidney, Polycystic, Autosomal Dominant
Drug: anti-hypertensive medications

Study Type: Interventional
Study Design: Primary Purpose: Treatment

Resource links provided by NLM:


Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

  Eligibility

Ages Eligible for Study:   15 Years to 65 Years   (Child, Adult)
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • Previous diagnosis of autosomal dominant polycystic kidney disease by abdominal imaging
  • Previous diagnosis of high blood pressure or current blood pressures above 130/80 mm Hg
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00067977

Locations
United States, Colorado
University of Colorado Health Sciences Center
Denver, Colorado, United States, 80262
United States, Georgia
Emory University
Atlanta, Georgia, United States
United States, Kansas
Kansas University Medical Center
Kansas City, Kansas, United States
United States, Massachusetts
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Tufts - New England Medical Center
Boston, Massachusetts, United States
United States, Minnesota
Mayo Clinic
Rochester, Minnesota, United States
United States, Ohio
Cleveland Clinic Foundation
Cleveland, Ohio, United States
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  More Information

ClinicalTrials.gov Identifier: NCT00067977     History of Changes
Other Study ID Numbers: ADPKD 
Study First Received: September 3, 2003
Last Updated: November 2, 2005
Health Authority: United States: Federal Government

Keywords provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):
PKD
ADPKD
polycystic kidney disease
autosomal dominant polycystic kidney disease

Additional relevant MeSH terms:
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Dominant
Kidney Diseases, Cystic
Kidney Diseases
Urologic Diseases
Antihypertensive Agents

ClinicalTrials.gov processed this record on December 02, 2016